Ceribelli Angela, Isailovic Natasa, De Santis Maria, Generali Elena, Satoh Minoru, Selmi Carlo
Division of Rheumatology and Clinical Immunology, Laboratory of Autoimmunity and Metabolism, Humanitas Research Hospital, Rozzano, Milan, Italy.
Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan.
J Immunol Methods. 2018 Jan;452:1-5. doi: 10.1016/j.jim.2017.10.001. Epub 2017 Oct 4.
To describe a new immunoprecipitation pattern identified in Italian patients affected by systemic sclerosis (SSc), corresponding to the pyruvate dehydrogenase antigen complex recognized by anti-mitochondrial antibodies (AMA) in primary biliary cholangitis (PBC).
Autoantibodies in sera from 85 patients with SSc were tested by protein- and RNA-immunoprecipitation. Immunoprecipitation-Western blot was used to determine the identified proteins, and medical records re-evaluated for liver function tests and PBC.
In 13/85 (15%) SSc sera, a unique set of 75-50-40-34kD proteins that had not been previously reported, was noted. The four proteins were identified as the proteins X/E3BP, E1α, E1β, and E2/E3 of the pyruvate dehydrogenase antigen complex by immunoprecipitation-Western blot. From clinical record evaluation, 9/13 (69%) SSc patients with this new pattern were positive for AMA by routine indirect immunofluorescence, and 7/13 (54%) had a diagnosis of PBC, while 4/13 (31%) manifested no biochemical signs of cholestasis. Twelve of 13 patients with SSc and AMA by immunoprecipitation have a limited cutaneous form of SSc and anti-centromere antibodies.
We describe a pattern of 4 proteins in 15% of SSc patients, identified for the first time by protein-immunoprecipitation. This pattern corresponds to serum AMA against the pyruvate dehydrogenase antigen complex and it must be considered in the interpretation of protein-immunoprecipitation results.
描述在意大利系统性硬化症(SSc)患者中发现的一种新的免疫沉淀模式,该模式与原发性胆汁性胆管炎(PBC)中抗线粒体抗体(AMA)识别的丙酮酸脱氢酶抗原复合物相对应。
采用蛋白质免疫沉淀和RNA免疫沉淀法检测85例SSc患者血清中的自身抗体。免疫沉淀-蛋白质印迹法用于确定所识别的蛋白质,并重新评估病历中的肝功能检查和PBC情况。
在85份SSc血清中的13份(15%)中,发现了一组独特的75-50-40-34kD蛋白质,此前未见报道。通过免疫沉淀-蛋白质印迹法,这四种蛋白质被鉴定为丙酮酸脱氢酶抗原复合物的蛋白质X/E3BP、E1α、E1β和E2/E3。从临床记录评估来看,13例具有这种新模式的SSc患者中,9例(69%)通过常规间接免疫荧光法AMA呈阳性,7例(54%)被诊断为PBC,而有4例(31%)未表现出胆汁淤积的生化迹象。13例通过免疫沉淀法检测出AMA的SSc患者中有12例为局限性皮肤型SSc且伴有抗着丝点抗体。
我们描述了15%的SSc患者中出现的一种由4种蛋白质组成的模式,并首次通过蛋白质免疫沉淀法得以鉴定。这种模式对应于针对丙酮酸脱氢酶抗原复合物的血清AMA,在解释蛋白质免疫沉淀结果时必须予以考虑。